Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Veracyte (VCYT) over the last 3 years, with Q3 2025 value amounting to $51.1 million.

  • Veracyte's Change in Acquisitions & Divestments changed N/A to $51.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.1 million, marking a year-over-year increase of 18899259.26%. This contributed to the annual value of $39.8 million for FY2023, which is 21385.54% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Change in Acquisitions & Divestments is $51.1 million.
  • Veracyte's 5-year Change in Acquisitions & Divestments high stood at $51.1 million for Q3 2025, and its period low was -$15000.0 during Q4 2022.
  • In the last 3 years, Veracyte's Change in Acquisitions & Divestments had a median value of $6.3 million in 2022 and averaged $17.3 million.
  • Examining YoY changes over the last 5 years, Veracyte's Change in Acquisitions & Divestments showed a top increase of 28000.0% in 2023 and a maximum decrease of 28000.0% in 2023.
  • Quarter analysis of 3 years shows Veracyte's Change in Acquisitions & Divestments stood at -$15000.0 in 2022, then surged by 280.0% to $27000.0 in 2023, then soared by 188992.59% to $51.1 million in 2025.
  • Its last three reported values are $51.1 million in Q3 2025, $27000.0 for Q4 2023, and $39.8 million during Q1 2023.